tiprankstipranks
Trending News
More News >

Enlivex Therapeutics selected to present at Israeli BioMed 2025 conference

Enlivex Therapeutics (ENLV) announced that the Company has been selected to present at the upcoming Israeli BioMed 2025 Conference, taking place May 21-23, 2025 in Tel Aviv, Israel. The Company’s presentation is titled “Enlivex-Harnessing the Natural Healing Power of Macrophages to Treat Inflammatory Diseases” and will be delivered by the Company’s CEO on May 21st as part of the session “Personalized Pathways; Genetic and Cellular Based Therapies for Rare and Complex Diseases”. Allocetra, Enlivex’s universal, off-the-shelf cell therapy, is designed to reset macrophages-key immune cells-to their homeostatic, or “balanced,” state. Non-homeostatic macrophages are implicated in a broad range of chronic and life-threatening diseases, and Allocetra’s unique reprogramming capability may offer a promising strategy for immune system rebalancing and disease resolution.

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1